SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is facing intense selling pressure despite reporting record earnings, as investors react to concerns over increased capital expenditures and broader market volatility linked to geopolitical tensions. While the company maintains a strong fundamental outlook due to surging AI-driven memory demand, the community is deeply divided between those labeling the price action as institutional manipulation and those warning that the stock could see further downside toward the 300 level.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a fiscal Q4 earnings report that featured a significant earnings per share beat alongside revenue that trailed expectations, keeping the focus squarely on the company's multi-billion dollar cash position and ongoing pivot toward becoming a holding company. While the community remains deeply divided, with some investors bullish on the long-term cash generation and potential for a future acquisition, others are actively debating a proposed executive compensation package and expressing frustration over the lack of a clear operational roadmap or immediate share price momentum.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to a significant $1 billion strategic equity investment in Nanya Technology, a move aimed at bolstering long-term memory sourcing that has left investors divided between seeing it as a growth catalyst and a cause for short-term price pressure. While some traders are actively buying the dip, citing the potential for strategic expansion, others are debating whether this massive capital outlay represents an overextension or a necessary maneuver in a supply-constrained memory sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing positive momentum following its recent announcement of clinical data from its siRNA pipeline targeting FSHD1 and DM1, which has generated significant community discussion regarding the company's potential to re-rate as a leading gene therapy player. Investors are actively debating the stock's valuation gap and upcoming catalysts, with strong sentiment favoring the company's robust pipeline and long-term fundamentals despite the sector's historical volatility.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors react to the company's aggressive M&A strategy, including the acquisition of World View, and raised 2026 revenue guidance that sparked intense debate over valuation and dilution. The community is focused on the upcoming earnings call, with active discussions weighing the stock's potential as a defense powerhouse against concerns regarding high short interest and institutional volatility.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors debate whether the company's recent push into mortgage innovation and improved operational velocity signals a legitimate turnaround or leaves it exposed to broader macroeconomic headwinds. The community is actively split between bulls optimistic about the firm's growth potential and short-sellers betting that ongoing market volatility and real estate sector pressures will drive further downside.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant attention as retail investors view it as a primary proxy for gaining exposure to a potential SpaceX IPO. Community members are actively debating the stock's valuation premium relative to its underlying net asset value while monitoring signals from Elon Musk and speculative chatter regarding upcoming IPO timelines.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing extreme volatility and rapid price appreciation driven by intense retail demand for exposure to pre-IPO giants like SpaceX and Anthropic. While some investors see this as a unique opportunity to access elite private tech companies, others warn of a significant overvaluation due to the massive premium over Net Asset Value and the looming supply pressure from restricted shares set to unlock later this year.

🌍 Introduction: A Legendary Icon, Reimagined for the Future The SEAMANIA Protocol, led by SEAMAN Cult, aims to revive one of SEGA Dreamcast's most iconic and best-selling game titles with AI integration—a worldwide cultural phenomenon that won numerous awards in the U.S. and Japan. More than just a game, SEAMAN was the world’s first AI-powered interactive experience, enabling voice-based conversations long before the AI revolution.    Now, SEAMAN returns not as a mere game, but as an advanced AI agent, blending nostalgia with cutting-edge technology. This human-faced fish is reborn as a deeply intelligent, emotionally responsiveAI, offering limitless customization and integration into the modern digital world.  With GenAI-powered customization, users can create their own SEAMAN AI, shaping it into a cherished lostone, a favorite celebrity, or even historical figures. This is no longer a game—it's an AI-driven personal companion and the digital evolution for human interaction.    🔥 Concept: The Wisdom of a Legendary AI-powered Companion At the core of the SEAMANIA Protocol lies the legendary Seaman—a mystical, human-faced fish endowed withancient wisdom and the ability to understand human language. More than just an AI, it is your trustedadvisor, best friend, therapist, personal cheerleader, witty conversationalist, intelligent guide, SEAMANIA is a life coach. Housed in your own digital aquarium, your SEAMAN AI reduces stress, combats loneliness, and guides humanity towards a brighter future. Imagine an AI companion that doesn’t just respond but truly understands, entertains, and supports you—blending humor, sarcasm, and wisdom.

SEAMANIA

SEAMANIA is gaining traction as a high-volatility meme coin, with community members actively coordinating buying pressure and drawing comparisons to other recent rapid runners in the crypto space. Participants are heavily focused on the potential for massive percentage gains while debating the sustainability of the price action and the speculative nature of the asset.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors debate the company's high valuation and long-term AI growth potential ahead of upcoming earnings. While some community members are bullish on Arm's expanded role in data center CPUs and robotics, others remain skeptical, pointing to significant price volatility and questioning if current performance justifies the premium.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Merck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Josh Gottheimer

Representative Josh Gottheimer (Democratic-New Jersey) recently bought shares of Merck & Co., Inc. (NYSE:MRK). In a filing disclosed on March 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in Merck & Co., Inc. stock on February 4th. The trade occurred in the Repre...

Merck &amp; Co. Inc. (MRK) has struck a multibillion-dollar deal to expand its oncology pipeline, agreeing to acquire clinical-stage biotech firm Terns Pharmaceuticals Inc. (TERN) for $53 per share in cash, at an approximate $6.7 billion valuation.&nbsp;The offer represents a 6% premium over Terns’ closing price as of Tuesday.&nbsp;Central to the acquisition is Terns’ experimental therapy, TERN-701, an oral treatment targeting specific mutations linked to chronic myeloid leukemia. The drug candidate is currently under evaluation in mid-stage clinical trials.&nbsp;Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/TERN">Terns Pharmaceuticals’ stock</a> traded over 4% higher in Wednesday’s premarket.&nbsp;Get updates to this developing story directly on Stocktwits.

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck To Acquire Terns In $6.7B Deal – Signaling Fresh Push In Competitive Cancer Drug Race 

At the core of the deal is Terns’ investigational drug TERN-701, an oral therapy designed to address mutations associated with chronic myeloid leukemia.

Equity

At the core of the deal is Terns’ investigational drug TERN-701, an oral therapy designed to address mutations associated with chronic myeloid leukemia.


Pensionfund Sabic Makes New $3.05 Million Investment in Merck & Co., Inc. $MRK

Pensionfund Sabic purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange...

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (Terns) (Nasdaq: TERN), a clinical-stage oncology company, today announced that the companies...

SLS Vs. TERN: Which Pharma Stock Has More Upside As Merck Eyes $6B Cancer Bet Ahead Of Keytruda Patent Cliff

SLS vs TERN Stock - Analyst estimates suggest SLS may offer 73% upside, versus 16% for TERN, despite takeover momentum supporting TERN’s shares.

Analyst estimates suggest SLS may offer 73% upside, versus 16% for TERN, despite takeover momentum supporting TERN’s shares.

E. Ohman J or Asset Management AB Purchases Shares of 88,457 Merck & Co., Inc. $MRK

E. Ohman J or Asset Management AB acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the...

Contravisory Investment Management Inc. Purchases 70,550 Shares of Merck & Co., Inc. $MRK

Contravisory Investment Management Inc. boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 19,435.3% in the fourth quarter, according to the company in its most recent...

Central Bank & Trust Co. Sells 13,216 Shares of Merck & Co., Inc. $MRK

Central Bank & Trust Co. decreased its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 31.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,470 shares of the compa...

Avanza Fonder AB Purchases 25,344 Shares of Merck & Co., Inc. $MRK

Avanza Fonder AB increased its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 289,720 shares of the company's stock after buying an addit...

Merck (MRK) Exceeds Market Returns: Some Facts to Consider

Merck (MRK) reached $115.68 at the closing of the latest trading day, reflecting a +1.31% change compared to its last close.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

The multibillion-dollar acquisition of Terns Pharmaceuticals is driving massive interest as traders speculate on which biotech firm is next in line.

Investors are closely watching the company’s strategic pipeline expansion to replace revenue from the aging Keytruda patent.

Collaborations like the Moderna cancer vaccine show strong 5-year data, reinforcing the company's commitment to cutting-edge oncology solutions.

MRK
Merck & Co Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRK News

MRKMerck & Co Inc